Author

Mike A. Briggs

Observed name: Mike Briggs

Observed institutions: GlaxoSmithKline (United Kingdom), Servier (United Kingdom)

OpenAlex ID: A5071204974

Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling

2000 · Jan J.P. Bogaards, Erna M. Hissink, et al. · European Journal of Pharmaceutical Sciences · 46

Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis

2019 · Mary Mcelroy, James Baily, et al. · European Respiratory Journal · 2

Abstract A143: A preclinical in vivo model to assess pharmacodynamic inhibition of ACK1.

2013 · Mark Albertella, Shilina Roman, et al. · Molecular Cancer Therapeutics

IC–P–124: Pharmacological MRI of H3 receptor antagonist GSK189254 in the rat brain

2006 · Diana Cash, Lorna Tilling, et al. · Alzheimer s & Dementia

P1–447: Pharmacological MRI of H3 receptor antagonist GSK189254 in the rat brain

2006 · Diana Cash, Lorna Tilling, et al. · Alzheimer s & Dementia

Works count: 5

Citation count: 48

H-index: 2

I10-index: 1